A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: The COPE-III study protocol

Contemporary Clinical Trials

Volumn 36, Issue 1, 2013, Pages 81-89

  Lenferink, Anke ^a   Frith, Peter ^b,c   van der Valk, Paul ^a   Buckman, Julie ^e   Sladek, Ruth ^c   Cafarella, Paul ^b,c   van der Palen, Job ^a,d   Effing, Tanja ^b,c  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF TWENTE   (Netherlands)

^e FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Chronic Obstructive Pulmonary Disease; Clinical protocols; Comorbidity; Randomized controlled trial; Research design; Self care

Indexed keywords

ADULT; ANXIETY; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SELF CONCEPT; SOCIAL SUPPORT;

AD; ANXIETY AND/OR DEPRESSION; AR-DRG; AUSTRALIAN REFINED DIAGNOSIS RELATED GROUPS; BODE; BODY MASS INDEX, OBSTRUCTION, DYSPNOEA, EXERCISE CAPACITY; CAT; CCMP; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL PROTOCOLS; COMORBIDITY; COMPREHENSIVE CARE MANAGEMENT PROGRAM; COPD; COPD ASSESSMENT TEST; COPD SELF-EFFICACY SCALE; CRQ; CSES; DATA SAFETY MONITORING BOARD; DSMB; EQ VAS; EQ-5D; ESC; EUROPEAN SOCIETY OF CARDIOLOGY; EUROQOL VISUAL ANALOGUE SCALE; EUROQOL-5 DIMENSIONS; FEV(1); FEV(6); FORCED (EXPIRATORY) VITAL CAPACITY; FORCED EXPIRATORY VOLUME IN ONE SECOND; FORCED EXPIRATORY VOLUME IN SIX SECONDS; FVC; GENERAL PRACTITIONER; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; GOLD; GP; HADS; HBA1C; HEALTH LITERACY; HEMOGLOBIN A1C; HL; HOSPITAL ANXIETY AND DEPRESSION SCALE; ICFS; IDENTITY-CONSEQUENCE FATIGUE SCORE; MBS; MEDICARE BENEFITS SCHEDULE; MINI MENTAL STATE EXAMINATION; MMRC; MMSE; MODIFIED MEDICAL RESEARCH COUNCIL; PARTNERS IN HEALTH; PAS; PATIENT ACTIVATION STATUS; PBS; PHARMACEUTICAL BENEFIT SCHEME; PIH; RANDOMIZED CONTROLLED TRIAL; RESEARCH DESIGN; SD; SELF CARE; STANDARD DEVIATION;

ANXIETY; CARDIOVASCULAR DISEASES; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; HEALTH SERVICES; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESEARCH DESIGN; SELF CARE; SELF EFFICACY;

EID: 84880303447     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.06.003     Document Type: Article

References (61)

1. Jemal A., Ward E., Hao Y., Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005 Sep 14, 294(10):1255-1259.
2. Australian Institute of Health and Welfare Australia's health 2010: the twelfth biennial health report of the Australian Institute of Health and Welfare. The health of Australians - an overview 2010, 19-59.
3. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 May, 157(5 Pt 1):1418-1422.
4. Celli B.R., Barnes P.J. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007 Jun, 29(6):1224-1238.
5. Rutten-van Molken M.P., Postma M.J., Joore M.A., Van Genugten M.L., Leidl R., Jager J.C. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 1999 Nov, 93(11):779-787.
6. Oostenbrink J.B., Rutten-van Molken M.P. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004 Sep, 98(9):883-891.
7. Holguin F., Folch E., Redd S.C., Mannino D.M. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005 Oct, 128(4):2005-2011.
8. Crockett A.J., Cranston J.M., Moss J.R., Alpers J.H. An association between length of stay and co-morbidity in chronic airflow limitation. Int J Qual Health Care 2000 Feb, 12(1):41-46.
9. Parappil A., Depczynski B., Collett P., Marks G.B. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology 2010 Aug, 15(6):918-922.
10. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008 Oct, 32(4):962-969.
11. Curkendall S.M., DeLuise C., Jones J.K., Lanes S., Stang M.R., Goehring E., et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006 Jan, 16(1):63-70.
12. Sidney S., Sorel M., Quesenberry C.P., DeLuise C., Lanes S., Eisner M.D. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005 Oct, 128(4):2068-2075.
13. Rutten F.H., Cramer M.J., Grobbee D.E., Sachs A.P., Kirkels J.H., Lammers J.W., et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005 Sep, 26(18):1887-1894.
14. McCullough P.A., Hollander J.E., Nowak R.M., Storrow A.B., Duc P., Omland T., et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 2003 Mar, 10(3):198-204.
15. Schnell K., Weiss C.O., Lee T., Krishnan J.A., Leff B., Wolff J.L., et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 2012, 12:26.
16. Maurer J., Rebbapragada V., Borson S., Goldstein R., Kunik M.E., Yohannes A.M., et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008 Oct, 134(4 Suppl.):43S-56S.
17. Feary J.R., Rodrigues L.C., Smith C.J., Hubbard R.B., Gibson J.E. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010 Nov, 65(11):956-962.
18. Anecchino C., Rossi E., Fanizza C., De R.M., Tognoni G., Romero M. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis 2007, 2(4):567-574.
19. Effing T., Zielhuis G., Kerstjens H., van der Valk P., van der Palen J. Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med 2011 Mar, 105(3):418-426.
20. Lorig K.R., Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 2003 Aug, 26(1):1-7.
21. Effing T., Kerstjens H., van der Valk P., Zielhuis G., van der Palen J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009 Nov, 64(11):956-962.
22. Rice K.L., Dewan N., Bloomfield H.E., Grill J., Schult T.M., Nelson D.B., et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010 Jan 14.
23. Effing T., Monninkhof E.M., van der Valk P.D., van der Palen J., van Herwaarden C.L., Partidge M.R., et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007, 4. CD002990.
24. Walters J.A., Turnock A.C., Walters E.H., Wood-Baker R. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010, 5. CD005074.
25. Morgan M.D. Action plans for COPD self-management. Integrated care is more than the sum of its parts. Thorax 2011 Nov, 66(11):935-936.
26. Bourbeau J. The role of collaborative self-management in pulmonary rehabilitation. Semin Respir Crit Care Med 2009 Dec, 30(6):700-707.
27. Effing T.W., Bourbeau J., Vercoulen J., Apter A.J., Coultas D., Meek P., et al. Self-management programmes for COPD: moving forward. Chron Respir Dis 2012 Feb, 9(1):27-35.
28. Altman D.G., Bland J.M. Treatment allocation by minimisation. BMJ 2005 Apr 9, 330(7495):843.
29. Mahler D.A., Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest 1988 Mar, 93(3):580-586.
30. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15, 176(6):532-555.
31. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 Oct, 29(19):2388-2442.
32. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67:361-370.
33. Spinhoven P., Ormel J., Sloekers P.P., Kempen G.I., Speckens A.E., Van Hemert A.M. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997 Mar, 27(2):363-370.
34. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 Nov, 12(3):189-198.
35. Trappenburg J.C., Monninkhof E.M., Bourbeau J., Troosters T., Schrijvers A.J., Verheij T.J., et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax 2011 Nov, 66(11):977-984.
36. Michie S., van Stralen M.M., West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011, 6:42.
37. Michie S., Johnston M. Theories and techniques of behaviour change: developing a cumulative science of behaviour change. Health Psychol Rev 2012, 6(1):1-6.
38. Jones P., Harding G., Wiklund I., Berry P., Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009 Sep, 18(3):208-215.
39. Jones P.W., Harding G., Berry P., Wiklund I., Chen W.H., Kline L.N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009 Sep, 34(3):648-654.
40. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes dO, Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004 Mar 4, 350(10):1005-1012.
41. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
42. Chew L.D., Griffin J.M., Partin M.R., Noorbaloochi S., Grill J.P., Snyder A., et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med 2008 May, 23(5):561-566.
43. Heller A., Elliott M.N., Haviland A.M., Klein D.J., Kanouse D.E. Patient activation status as a predictor of patient experience among Medicare beneficiaries. Med Care 2009 Aug, 47(8):850-857.
44. Criteria Committee of the New York Heart Association Nomenclature and criteria for diagnosis of diseases of the heart and great vessels 1994, 253-256. Little, Brown Book Group Limited, [Boston]. 9th ed. Brown & Co. (Ed.).
45. Butland R.J., Pang J., Gross E.R., Woodcock A.A., Geddes D.M. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982 May 29, 284(6329):1607-1608.
46. Anthonisen N.R., Manfreda J., Warren C.P., Hershfield E.S., Harding G.K., Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987 Feb, 106(2):196-204.
47. Guyatt G.H., Berman L.B., Townsend M., Pugsley S.O., Chambers L.W. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987 Oct, 42(10):773-778.
48. Burt M.G., Roberts G.W., Aguilar-Loza N.R., Frith P., Stranks S.N. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab 2011 Jun, 96(6):1789-1796.
49. Lingam R., Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002 Mar, 105(3):164-172.
50. Australian Lung Foundation COPD action plan 2011, Australian Lung Foundation, [cited 12A.D. Oct 23].
51. Fan V.S., Gaziano J.M., Lew R., Bourbeau J., Adams S.G., Leatherman S., et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 2012 May 15, 156(10):673-683.
52. Bucknall C.E., Miller G., Lloyd S.M., Cleland J., McCluskey S., Cotton M., et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ 2012, 344:e1060.
53. Sabati N., Snyder M., Edin-Stibbe C., Lindgren B., Finkelstein S. Facilitators and barriers to adherence with home monitoring using electronic spirometry. AACN Clin Issues 2001 May, 12(2):178-185.
54. Bourbeau J., Bartlett S.J. Patient adherence in COPD. Thorax 2008 Sep, 63(9):831-838.
55. Bischoff E.W., Hamd D.H., Sedeno M., Benedetti A., Schermer T.R., Bernard S., et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax 2011 Jan, 66(1):26-31.
56. Bell E., Orpin P. Self-management of chronic conditions: implications for rural physicians of a demonstration project Down Under. Can J Rural Med 2006, 11(1):33-40.
57. EuroQol-a new facility for the measurement of health-related quality of life The EuroQol Group. Health Policy 1990 Dec, 16(3):199-208.
58. Rabin R. de CF. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001 Jul, 33(5):337-343.
59. Paddison J.S., Booth R.J., Hill A.G., Cameron L.D. Comprehensive assessment of peri-operative fatigue: development of the Identity-Consequence Fatigue Scale. J Psychosom Res 2006 Jun, 60(6):615-622.
60. Petkov J., Harvey P., Battersby M. The internal consistency and construct validity of the partners in health scale: validation of a patient rated chronic condition self-management measure. Qual Life Res 2010 Sep, 19(7):1079-1085.
61. Wigal J.K., Creer T.L., Kotses H. The COPD Self-Efficacy Scale. Chest 1991 May, 99(5):1193-1196.